Mednax Can Susstain EPS Growth By Consolidating Nanotechnology, Morgan Keegan Reports - Pediatrix Medical Group (NYSE:MD)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

In a report released this morning, Morgan Keegan said that it believes that Mednax, Inc. (NYSE: MD) can sustain EPS growth by consolidating neonatology, anesthesiology, and related group medical practices.“We believe the company's entry into the anesthesiology sector will enable it to continue to grow through accretive all-cash acquisitions of medical groups,” Morgan Keegan writes. “Our Market Perform rating is due to continued soft neonatology intensive care unit volumes and our concern that an increased proportion of lower-paying government-reimbursed admissions could occur.”Morgan Keegan said that its EPS estimate of $1.05 versus $1.03 in the prior year period is in line with the First Call consensus, adding, “We are confident that the company's earnings will at least meet Mednax's guidance of $1.03-$1.07.”Mednax closed Friday at $56.96.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!